• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与成年人相比,婴幼儿对新冠病毒感染产生的抗体反应更持久。

Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.

作者信息

Joshi Devyani, Nyhoff Lindsay E, Zarnitsyna Veronika I, Moreno Alberto, Manning Kelly, Linderman Susanne, Burrell Allison R, Stephens Kathy, Norwood Carson, Mantus Grace, Ahmed Rafi, Anderson Evan J, Staat Mary A, Suthar Mehul S, Wrammert Jens

机构信息

Division of Infectious Diseases, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA, USA.

Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.

出版信息

iScience. 2023 Sep 20;26(10):107967. doi: 10.1016/j.isci.2023.107967. eCollection 2023 Oct 20.

DOI:10.1016/j.isci.2023.107967
PMID:37822504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10562792/
Abstract

As SARS-CoV-2 becomes endemic, it is critical to understand immunity following early-life infection. We evaluated humoral responses to SARS-CoV-2 in 23 infants/young children. Antibody responses to SARS-CoV-2 spike antigens peaked approximately 30 days after infection and were maintained up to 500 days with little apparent decay. While the magnitude of humoral responses was similar to an adult cohort recovered from mild/moderate COVID-19, both binding and neutralization titers to WT SARS-CoV-2 were more durable in infants/young children, with spike and RBD IgG antibody half-life nearly 4X as long as in adults. IgG subtype analysis revealed that while IgG1 formed the majority of the response in both groups, IgG3 was more common in adults and IgG2 in infants/young children. These findings raise important questions regarding differential regulation of humoral immunity in infants/young children and adults and could have broad implications for the timing of vaccination and booster strategies in this age group.

摘要

随着严重急性呼吸综合征冠状病毒2(SARS-CoV-2)成为地方性流行病毒,了解早期感染后的免疫情况至关重要。我们评估了23名婴幼儿对SARS-CoV-2的体液免疫反应。对SARS-CoV-2刺突抗原的抗体反应在感染后约30天达到峰值,并维持长达500天,几乎没有明显衰减。虽然体液免疫反应的强度与从轻度/中度新冠肺炎中康复的成人队列相似,但婴幼儿对野生型SARS-CoV-2的结合和中和滴度更持久,刺突和受体结合域(RBD)IgG抗体半衰期几乎是成人的4倍。IgG亚型分析显示,虽然两组中IgG1在反应中占多数,但IgG3在成人中更常见,而IgG2在婴幼儿中更常见。这些发现提出了关于婴幼儿和成人体液免疫差异调节的重要问题,并可能对该年龄组的疫苗接种时间和加强免疫策略产生广泛影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/d8122bb6e22e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/388c37fc6d6f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/dd77e38a8abb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/b06ef0a406b3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/5c848cd8240e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/99491a2eaa28/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/310afaac0937/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/d8122bb6e22e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/388c37fc6d6f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/dd77e38a8abb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/b06ef0a406b3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/5c848cd8240e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/99491a2eaa28/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/310afaac0937/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bea/10562792/d8122bb6e22e/gr6.jpg

相似文献

1
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.与成年人相比,婴幼儿对新冠病毒感染产生的抗体反应更持久。
iScience. 2023 Sep 20;26(10):107967. doi: 10.1016/j.isci.2023.107967. eCollection 2023 Oct 20.
2
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults.与成年人相比,婴幼儿对SARS-CoV-2感染产生的抗体反应更持久。
medRxiv. 2023 Apr 11:2023.04.10.23288360. doi: 10.1101/2023.04.10.23288360.
3
SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.埃塞俄比亚霍瓦萨地区学龄儿童中的 SARS-CoV-2 感染和 mRNA 疫苗诱导的体液免疫。
Front Immunol. 2023 Jun 15;14:1163688. doi: 10.3389/fimmu.2023.1163688. eCollection 2023.
4
Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination.先前存在的 SARS-CoV-2 免疫会影响对 SARS-CoV-2 疫苗接种的体液免疫反应的效力、广度和持久性。
Cell Rep Med. 2022 Mar 29;3(4):100603. doi: 10.1016/j.xcrm.2022.100603. eCollection 2022 Apr 19.
5
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.新型冠状病毒 ARCoV mRNA 疫苗在中国成年人中的安全性和免疫原性:一项随机、双盲、安慰剂对照、1 期临床试验。
Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24.
6
Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection.儿童慢性乙型肝炎感染者接种灭活 COVID-19 疫苗后 1 年内的体液免疫反应。
Front Cell Infect Microbiol. 2023 Jun 29;13:1201101. doi: 10.3389/fcimb.2023.1201101. eCollection 2023.
7
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应(UNCoVER):一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
8
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects.双重接种 SARS-CoV-2 疫苗的个体和接受 COVID-19 康复者加强针接种的个体的体液免疫。
Infection. 2022 Dec;50(6):1475-1481. doi: 10.1007/s15010-022-01817-8. Epub 2022 Apr 11.
9
Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort.完全接种疫苗的个体中体液和细胞免疫应答,无论是否发生 SARS-CoV-2 突破感染:来自 CoV-ADAPT 队列的结果。
J Med Virol. 2023 Oct;95(10):e29122. doi: 10.1002/jmv.29122.
10
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.理解“混合免疫”:对严重急性呼吸综合征冠状病毒 2 感染(SARS-CoV-2)和 2019 年冠状病毒病(COVID-19)疫苗的体液免疫反应的比较和预测因素。
Clin Infect Dis. 2023 Feb 8;76(3):e439-e449. doi: 10.1093/cid/ciac392.

引用本文的文献

1
Pulmonary and Immune Dysfunction in Pediatric Long COVID: A Case Study Evaluating the Utility of ChatGPT-4 for Analyzing Scientific Articles.儿童长期新冠后的肺部和免疫功能障碍:一项评估ChatGPT-4分析科学文章效用的案例研究
J Clin Med. 2025 Aug 25;14(17):6011. doi: 10.3390/jcm14176011.
2
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults.儿童对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗体反应比成人表现出更高的Fc受体结合能力和亲和力。
Nat Commun. 2025 Aug 23;16(1):7879. doi: 10.1038/s41467-025-63263-y.
3
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer.

本文引用的文献

1
SARS-CoV-2 variant biology: immune escape, transmission and fitness.SARS-CoV-2 变体生物学:免疫逃逸、传播和适应性。
Nat Rev Microbiol. 2023 Mar;21(3):162-177. doi: 10.1038/s41579-022-00841-7. Epub 2023 Jan 18.
2
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.来自mRNA二价加强针的针对BA.2.75.2、BQ.1.1和XBB的中和作用。
N Engl J Med. 2023 Jan 12;388(2):183-185. doi: 10.1056/NEJMc2214293. Epub 2022 Dec 21.
3
The adaptive immune system in early life: The shift makes it count.生命早期的适应性免疫系统:转变使之变得重要。
头颈癌患者对新型冠状病毒的体液免疫和细胞免疫反应
Viruses. 2025 Jun 13;17(6):848. doi: 10.3390/v17060848.
4
Long-Term Dynamics of SARS-CoV-2 Variant-Specific Neutralizing Antibodies Following mRNA Vaccination and Infection.mRNA疫苗接种和感染后SARS-CoV-2变体特异性中和抗体的长期动态变化
Viruses. 2025 May 6;17(5):675. doi: 10.3390/v17050675.
5
Immunogenicity of the CoronaVac vaccine in children: a real-world study.科兴新冠疫苗在儿童中的免疫原性:一项真实世界研究。
Front Immunol. 2024 Dec 23;15:1504935. doi: 10.3389/fimmu.2024.1504935. eCollection 2024.
6
Methods for Modeling Early Life Stress in Rodents.啮齿动物早期生活应激模型的建立方法。
Methods Mol Biol. 2025;2868:205-219. doi: 10.1007/978-1-0716-4200-9_11.
7
Seroprevalence of SARS-CoV-2 infection in pediatric patients in a tertiary care hospital setting.三级保健医院环境中儿科患者 SARS-CoV-2 感染的血清流行率。
PLoS One. 2024 Sep 24;19(9):e0310860. doi: 10.1371/journal.pone.0310860. eCollection 2024.
8
Variant-specific antibody profiling for tracking SARS-CoV-2 variant infections in children and adolescents.用于追踪儿童和青少年感染 SARS-CoV-2 变异株的变异特异性抗体分析。
Front Immunol. 2024 Aug 27;15:1434291. doi: 10.3389/fimmu.2024.1434291. eCollection 2024.
9
SARS-CoV-2 anti-RBD and anti-N protein responses are differentially regulated between mother-child pairs: insight from a national study cohort at the Faroe Islands.SARS-CoV-2 抗 RBD 和抗 N 蛋白反应在母婴对之间存在差异调节:法罗群岛全国研究队列的观察结果。
Front Immunol. 2024 Jul 3;15:1418678. doi: 10.3389/fimmu.2024.1418678. eCollection 2024.
10
Durability of immune responses to SARS-CoV-2 infection and vaccination.对新冠病毒感染和疫苗接种的免疫反应的持久性。
Semin Immunol. 2024 May;73:101884. doi: 10.1016/j.smim.2024.101884. Epub 2024 Jun 10.
Front Immunol. 2022 Nov 17;13:1031924. doi: 10.3389/fimmu.2022.1031924. eCollection 2022.
4
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody.通过一种广泛中和的 SARS-CoV-2 抗体对奥密克戎变异株 BA.1、BA.2、BA.4 和 BA.5 的中和作用的结构见解。
Sci Adv. 2022 Oct 7;8(40):eadd2032. doi: 10.1126/sciadv.add2032. Epub 2022 Oct 5.
5
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.COVID-19 加强针接种后免疫反应的持久性及其与 COVID-19 奥密克戎感染的关联。
JAMA Netw Open. 2022 Sep 1;5(9):e2231778. doi: 10.1001/jamanetworkopen.2022.31778.
6
The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity.奥密克戎变异株引发的 SARS-CoV-2 疫情、免疫逃逸和疫苗效力。
J Med Virol. 2023 Jan;95(1):e28138. doi: 10.1002/jmv.28138. Epub 2022 Sep 21.
7
Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies.早期季节性冠状病毒血清转化未产生交叉保护性的严重急性呼吸综合征冠状病毒2抗体。
J Infect. 2023 Jan;86(1):e10-e12. doi: 10.1016/j.jinf.2022.08.032. Epub 2022 Sep 5.
8
Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.青少年和成年人对 SARS-CoV-2 奥密克戎变异株的辉瑞(BNT162b2)疫苗诱导的抗体反应丧失。
J Virol. 2022 Sep 14;96(17):e0058222. doi: 10.1128/jvi.00582-22. Epub 2022 Aug 17.
9
The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.自然感染和疫苗诱导的免疫对未来感染 SARS-CoV-2 的持久性。
Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2204336119. doi: 10.1073/pnas.2204336119. Epub 2022 Jul 15.
10
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection.轻度感染 SARS-CoV-2 后儿童和成人的长期免疫反应
JAMA Netw Open. 2022 Jul 1;5(7):e2221616. doi: 10.1001/jamanetworkopen.2022.21616.